70 Years of Levothyroxine
Objektkategorie:
Elektronische Ressource
Person/Institution:
Verlag:
Springer International Publishing
Imprint: Springer
Veröffentlichungsort:
Cham
Entstehungszeit:
2021.
Umfang, Illustration, Format:
1 Online-Ressource(XVII, 129 p. 37 illus., 34 illus. in color.)
Sprache:
Englisch
Bereitstellende Institution:
Weitere Objektinformationen
Abstract:
History Of Levothyroxine -- Pharmacokinetics Of Levothyroxine -- Pharmacodynamics Of Levothyroxine -- Levothyroxine In Pregnancy -- Levothyroxine In Children -- Levothyroxine In The Elderly -- Levothyroxine And Heart -- Levothyroxine And Bone -- Levothyroxine And Cancer -- Potential Adverse Reactions Of Levothyroxine.
This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals.
This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals.
Objekttext:
edited by George J. Kahaly
Open Access
Open Access
Zugriff und Nutzungsmöglichkeiten
Kontaktinformationen
Universität Erfurt
Forschungsbibliothek Gotha
Schloss Friedenstein
Schlossplatz 1
99867 Gotha
+49 361 737-5540
bibliothek.gotha(at)uni-erfurt.de
Forschungsbibliothek Gotha
Schloss Friedenstein
Schlossplatz 1
99867 Gotha
+49 361 737-5540
bibliothek.gotha(at)uni-erfurt.de
Administrative Angaben
Datensatz angelegt am:
2023-04-13
Zuletzt geändert am:
2021-05-12
In Portal übernommen am:
2023-04-13
Feedback
Unsere Datensätze befinden sich in stetiger Weiterentwicklung. Wenn Sie zusätzliche Informationen zu diesem Objekt oder einen Fehler entdeckt haben, dann schreiben Sie uns. Informationen zum Datenschutz